Senseonics Holdings Inc. (SENS)

1.06
AMEX : Electronic Technology
Prev Close 1.08
Day Low/High 1.04 / 1.10
52 Wk Low/High 0.92 / 4.89
Avg Volume 2.01M
Exchange AMEX
Shares Outstanding 203.17M
Market Cap 219.42M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Senseonics Publishes Eversense® CGM Real-World Data From First U.S. Users

Senseonics Publishes Eversense® CGM Real-World Data From First U.S. Users

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced the...

Senseonics Holdings, Inc. Reports Second Quarter 2019 Financial Results

Senseonics Holdings, Inc. Reports Second Quarter 2019 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial...

Senseonics To Participate In The Canaccord Genuity Growth Conference

Senseonics To Participate In The Canaccord Genuity Growth Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the company...

Senseonics Holdings, Inc. Schedules Second Quarter 2019 Earnings Release And Conference Call For August 7, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. Schedules Second Quarter 2019 Earnings Release And Conference Call For August 7, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans...

Senseonics Announces Pricing Of Public Offering Of Common Stock

Senseonics Announces Pricing Of Public Offering Of Common Stock

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the pricing of a...

Senseonics Announces Public Offering Of Common Stock

Senseonics Announces Public Offering Of Common Stock

Senseonics Holdings, Inc. ("Senseonics") (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced...

Senseonics Announces Commencement Of Convertible Notes Offering

Senseonics Announces Commencement Of Convertible Notes Offering

Senseonics Holdings, Inc. ("Senseonics" or the "Company") (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes,...

Senseonics Holdings, Inc. Reports Preliminary Second Quarter 2019 Net Revenue

Senseonics Holdings, Inc. Reports Preliminary Second Quarter 2019 Net Revenue

Senseonics Holdings, Inc. ("Senseonics" or "Company") (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes,...

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made...

Senseonics Announces FDA Approval For A Non-Adjunctive Indication (Dosing Claim) For The Eversense® 90-day CGM System

Senseonics Announces FDA Approval For A Non-Adjunctive Indication (Dosing Claim) For The Eversense® 90-day CGM System

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that they received FDA...

Senseonics To Present Real-World, Long-Term Safety Data Of The First Implantable CGM Sensor At The American Diabetes Association's 79th Scientific Sessions

Senseonics To Present Real-World, Long-Term Safety Data Of The First Implantable CGM Sensor At The American Diabetes Association's 79th Scientific Sessions

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, will present the long-term...

Senseonics To Participate In The Raymond James Life Sciences And MedTech Conference

Senseonics To Participate In The Raymond James Life Sciences And MedTech Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the company...

Senseonics To Participate In The Guggenheim MedTech Disruptors Summit

Senseonics To Participate In The Guggenheim MedTech Disruptors Summit

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the company...

Senseonics Holdings, Inc. Reports First Quarter 2019 Financial Results

Senseonics Holdings, Inc. Reports First Quarter 2019 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the design, development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported...

First Week Of SENS June 21st Options Trading

First Week Of SENS June 21st Options Trading

Investors in Senseonics Holdings Inc saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SENS options chain for the new June 21st contracts and identified the following call contract of particular interest.

Senseonics Holdings, Inc. Schedules First Quarter 2019 Earnings Release And Conference Call For May 9, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. Schedules First Quarter 2019 Earnings Release And Conference Call For May 9, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans...

Senseonics Launches The Eversense® Bridge Patient Access Program In The U.S.

Senseonics Launches The Eversense® Bridge Patient Access Program In The U.S.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, has announced the launch of the...

Senseonics Holdings, Inc. Reports Fourth Quarter And Full Year 2018 Financial Results

Senseonics Holdings, Inc. Reports Fourth Quarter And Full Year 2018 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial...

Senseonics Announces Appointment Of Francine R. Kaufman, M.D. As Chief Medical Officer

Senseonics Announces Appointment Of Francine R. Kaufman, M.D. As Chief Medical Officer

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the appointment...

Senseonics Eversense® CGM Launches Integration With Glooko

Senseonics Eversense® CGM Launches Integration With Glooko

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the integration...

Senseonics To Participate In The Cowen Health Care Conference

Senseonics To Participate In The Cowen Health Care Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the company...

Senseonics Holdings, Inc. Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For March 12, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For March 12, 2019 At 4:30 P.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans...

Senseonics Announces Partnership With Geo-Med To Provide Veterans Access To Eversense CGM

Senseonics Announces Partnership With Geo-Med To Provide Veterans Access To Eversense CGM

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that it has...

Senseonics Announces Extension Of Distribution Agreement With Roche Diabetes Care

Senseonics Announces Extension Of Distribution Agreement With Roche Diabetes Care

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced an extension of...

Senseonics Eversense CGM Sensor Receives Indication For MRI

Senseonics Eversense CGM Sensor Receives Indication For MRI

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that they...

Senseonics Appoints Jon D. Isaacson As Chief Financial Officer

Senseonics Appoints Jon D. Isaacson As Chief Financial Officer

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the appointment...

Senseonics Announces First Study Participant Implanted In The U.S. As Part Of The PROMISE 180-Day Sensor Clinical Study And The Submission Of Key PMA Supplements To The FDA To Advance Current 90-Day Product

Senseonics Announces First Study Participant Implanted In The U.S. As Part Of The PROMISE 180-Day Sensor Clinical Study And The Submission Of Key PMA Supplements To The FDA To Advance Current 90-Day Product

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that the...

Senseonics Holdings, Inc. Announces Retirement Of Chief Financial Officer

Senseonics Holdings, Inc. Announces Retirement Of Chief Financial Officer

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the retirement...

TheStreet Quant Rating: D- (Sell)